Li L - Search Results

1

Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials.

Liang Z, Liu L, Li W, Lai H, Li L, Wu J, Zhang H, Fang C. Liang Z, et al. Among authors: li w, li l. Front Oncol. 2023 Oct 9;13:1258347. doi: 10.3389/fonc.2023.1258347. eCollection 2023. Front Oncol. 2023. PMID: 37886169 Free PMC article.

2

Effective Treatment of NSCLC with Surgery After Nivolumab Combined with Chemotherapy: A Case Report and Brief Review of the Literature.

Zhao L, Li L, Chen T, Fang C. Zhao L, et al. Among authors: li l. Onco Targets Ther. 2020 Dec 30;13:13307-13313. doi: 10.2147/OTT.S266155. eCollection 2020. Onco Targets Ther. 2020. PMID: 33408481 Free PMC article.

3

Ablation Therapy Combined with EGFR TKIs in the Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.

Li LZ, Wu JM, Chen T, Zhao LC, Zhuang JN, Hong HS, Zhang A, Zhang HT, Fang CT. Li LZ, et al. Evid Based Complement Alternat Med. 2021 May 7;2021:6624429. doi: 10.1155/2021/6624429. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34055015 Free PMC article.

4

Case report: pathological complete response in an IIIB non-small cell lung cancer patient after preoperative neoadjuvant nivolumab therapy combined with chemotherapy.

Li L, Chen T, Lai H, Zhang A, Zhao X, Wu J, Hong H, Wu L, Lin S, Wang K, Zhang H, Fang C. Li L, et al. Medicine (Baltimore). 2022 Jun 10;101(23):e29336. doi: 10.1097/MD.0000000000029336. Medicine (Baltimore). 2022. PMID: 35687776 Free PMC article.

5

Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.

Lin SH, Zhang A, Li LZ, Zhao LC, Wu LX, Fang CT. Lin SH, et al. BMC Endocr Disord. 2022 Sep 24;22(1):239. doi: 10.1186/s12902-022-01151-y. BMC Endocr Disord. 2022. PMID: 36153581 Free PMC article. Review.

6

A single-center randomized controlled study of intraperitoneal hyperthermic chemoperfusion in combination of recombinant human tumor necrosis factor (TNF) in treatment of malignant ascites caused by advanced abdominal cancers.

Wu L, Zhu W, Meng J, Wu J, Li L, Fang C, Zhang H. Wu L, et al. Among authors: li l. Medicine (Baltimore). 2022 Dec 2;101(48):e31883. doi: 10.1097/MD.0000000000031883. Medicine (Baltimore). 2022. PMID: 36482606 Free PMC article.

7

Major pathological remissions in a patient with stage IIIA nonsmall cell lung cancer after neoadjuvant tislelizumab combined with chemotherapy: a case report and literature review.

Li LZ, Lin SH, Wu LX, Chen T, Zhuang JN, Lai HQ, Liang ZP, Zhu WS, Li WX, Tang L, Zhang HT, Fang CT. Li LZ, et al. Among authors: li wx. Anticancer Drugs. 2023 Sep 1;34(8):962-966. doi: 10.1097/CAD.0000000000001497. Epub 2023 Jan 4. Anticancer Drugs. 2023. PMID: 36602434 Review.

8

Efficacy and safety of salvage radiotherapy combined with endocrine therapy in patients with biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis of randomized controlled trials.

Liang Z, Lin S, Lai H, Li L, Wu J, Zhang H, Fang C. Liang Z, et al. Among authors: li l. Front Oncol. 2023 Jan 24;12:1093759. doi: 10.3389/fonc.2022.1093759. eCollection 2022. Front Oncol. 2023. PMID: 36761425 Free PMC article.

9

Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis.

Liang Z, Chen T, Li W, Lai H, Li L, Wu J, Zhang H, Fang C. Liang Z, et al. Among authors: li w, li l. Medicine (Baltimore). 2024 Jan 19;103(3):e36785. doi: 10.1097/MD.0000000000036785. Medicine (Baltimore). 2024. PMID: 38241577 Free PMC article.

10

Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.

Zhang W, Liang Z, Zhao Y, Li Y, Chen T, Li W, Chen Y, Wu P, Zhang H, Fang C, Li L. Zhang W, et al. Among authors: li y, li w, li l. Front Immunol. 2024 Apr 5;15:1359302. doi: 10.3389/fimmu.2024.1359302. eCollection 2024. Front Immunol. 2024. PMID: 38646542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,556 results

Search Page

Filters